Drug · DIN 02241981
LEVOPHED
SINGLE-USE VIAL
No: no longer authorized
The company stopped selling it and its DIN was cancelled. A cancellation is most often a business decision; the record does not say why.
Status Cancelled Post Market since October 31, 2024; first marketed October 1, 2001.
- Drug Identification Number (DIN)
- 02241981
- Company (DIN owner)
- Pfizer Canada UlcKirkland, Quebec, Canada
- Schedule
- Ethical
- Dosage form
- Solution
- Route
- Intravenous
- Therapeutic class (ATC)
- Norepinephrine C01CA03
- Class
- Human
- Record last updated
- August 7, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| NOREPINEPHRINE (NOREPINEPHRINE BITARTRATE) | 1 MG | ML |
Recalls and safety alerts that mention it
Health Canada’s recall notices do not carry licence numbers, so these are matched by name: notices whose title or product names “levophed”. A notice may cover another product or only some lots: read it to see what it covers.
- LEVOPHED 1.0 mg/mL (2017-05-15)June 22, 2017 · Drugs · Product safety · Type II